Protalix BioTherapeutics, Inc. (PLX)
NYSEAMERICAN: PLX · Real-Time Price · USD
1.450
-0.010 (-0.68%)
Aug 1, 2025, 4:00 PM - Market closed
Verve Therapeutics Employees
Protalix BioTherapeutics had 213 employees as of December 31, 2024. The number of employees increased by 5 or 2.40% compared to the previous year.
Employees
213
Change (1Y)
5
Growth (1Y)
2.40%
Revenue / Employee
$280,582
Profits / Employee
$18,347
Market Cap
115.43M
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 213 | 5 | 2.40% |
Dec 31, 2023 | 208 | 11 | 5.58% |
Dec 31, 2022 | 197 | -9 | -4.37% |
Dec 31, 2021 | 206 | -1 | -0.48% |
Dec 31, 2020 | 207 | 11 | 5.61% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 94,300 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
PLX News
- 12 days ago - Protalix BioTherapeutics Appoints Gilad Mamlok as its New Senior Vice President and Chief Financial Officer - PRNewsWire
- 4 weeks ago - Protalix BioTherapeutics Added to Russell 3000® and 2000 Indexes® - PRNewsWire
- 2 months ago - Protalix BioTherapeutics to Present at the 3rd Annual H.C. Wainwright BioConnect Investor Conference at Nasdaq NYC - PRNewsWire
- 3 months ago - Protalix BioTherapeutics, Inc. (PLX) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 3 months ago - Protalix BioTherapeutics Reports First Quarter 2025 Financial and Business Results - PRNewsWire
- 3 months ago - Protalix BioTherapeutics to Announce First Quarter 2025 Financial and Business Results on May 9, 2025 - PRNewsWire
- 4 months ago - Protalix BioTherapeutics Is A Strong Buy With Increasing Revenues And A Promising Pipeline - Seeking Alpha
- 4 months ago - Protalix BioTherapeutics to Present at the iAccess Alpha Virtual Best Ideas Spring Conference 2025 - PRNewsWire